U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent B-Cell Prolymphocytic Leukemia

MedGen UID:
1674441
•Concept ID:
C4764032
•
Neoplastic Process

Definition

The reemergence of a B-cell prolymphocytic leukemia after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent B-Cell Prolymphocytic Leukemia

Professional guidelines

PubMed

Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB, Chapiro E, Daudignon A, Nadal N, Penther D, Chauzeix J, Nguyen-Khac F, Veronese L, Lefebvre C
Curr Res Transl Med 2023 Oct-Dec;71(4):103428. Epub 2023 Oct 31 doi: 10.1016/j.retram.2023.103428. PMID: 38016421
Management of prolymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program 2015;2015:361-7. doi: 10.1182/asheducation-2015.1.361. PMID: 26637744
Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Recent clinical studies

Etiology

Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB, Chapiro E, Daudignon A, Nadal N, Penther D, Chauzeix J, Nguyen-Khac F, Veronese L, Lefebvre C
Curr Res Transl Med 2023 Oct-Dec;71(4):103428. Epub 2023 Oct 31 doi: 10.1016/j.retram.2023.103428. PMID: 38016421
Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study.
Eyre TA, Schuh A, Wierda WG, Brown JR, Ghia P, Pagel JM, Furman RR, Cheung J, Hamdy A, Izumi R, Patel P, Wang MH, Xu Y, Byrd JC, Hillmen P
Lancet Haematol 2021 Dec;8(12):e912-e921. Epub 2021 Nov 1 doi: 10.1016/S2352-3026(21)00305-7. PMID: 34735860
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.
Shea T, Johnson J, Westervelt P, Farag S, McCarty J, Bashey A, Isola L, Baxter-Lowe LA, Kelly M, Owzar K, Linker C; Cancer and Leukemia Group B
Biol Blood Marrow Transplant 2011 Sep;17(9):1395-403. Epub 2011 Feb 3 doi: 10.1016/j.bbmt.2011.01.016. PMID: 21296675Free PMC Article
Mature T-cell leukemias.
Ravandi F, Kantarjian H, Jones D, Dearden C, Keating M, O'Brien S
Cancer 2005 Nov 1;104(9):1808-18. doi: 10.1002/cncr.21405. PMID: 16136598
Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Diagnosis

Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB, Chapiro E, Daudignon A, Nadal N, Penther D, Chauzeix J, Nguyen-Khac F, Veronese L, Lefebvre C
Curr Res Transl Med 2023 Oct-Dec;71(4):103428. Epub 2023 Oct 31 doi: 10.1016/j.retram.2023.103428. PMID: 38016421
Mycobacterial Spindle Cell Pseudotumor of the Nasal Cavity.
Argyris PP, Wakely PE Jr
Head Neck Pathol 2023 Sep;17(3):782-787. Epub 2023 Apr 7 doi: 10.1007/s12105-023-01550-0. PMID: 37027086Free PMC Article
Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia.
Kanagal-Shamanna R, Bao H, Kearney H, Smoley S, Tang Z, Luthra R, Yang H, Zhang S, Lin P, Wu D, Medeiros LJ, Lu X
Leuk Lymphoma 2022 Apr;63(4):865-875. Epub 2021 Dec 13 doi: 10.1080/10428194.2021.2010061. PMID: 34898335
Mature T-cell leukemias.
Ravandi F, Kantarjian H, Jones D, Dearden C, Keating M, O'Brien S
Cancer 2005 Nov 1;104(9):1808-18. doi: 10.1002/cncr.21405. PMID: 16136598
Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Therapy

Management of prolymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program 2015;2015:361-7. doi: 10.1182/asheducation-2015.1.361. PMID: 26637744
Mature T-cell leukemias.
Ravandi F, Kantarjian H, Jones D, Dearden C, Keating M, O'Brien S
Cancer 2005 Nov 1;104(9):1808-18. doi: 10.1002/cncr.21405. PMID: 16136598
Emerging information on the use of rituximab in chronic lymphocytic leukemia.
Keating MJ, O'Brien S, Albitar M
Semin Oncol 2002 Feb;29(1 Suppl 2):70-4. PMID: 11842391
Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261
Cytogenetics in CLL and related disorders.
Juliusson G, Gahrton G
Baillieres Clin Haematol 1993 Dec;6(4):821-48. doi: 10.1016/s0950-3536(05)80178-7. PMID: 8038492

Prognosis

Mycobacterial Spindle Cell Pseudotumor of the Nasal Cavity.
Argyris PP, Wakely PE Jr
Head Neck Pathol 2023 Sep;17(3):782-787. Epub 2023 Apr 7 doi: 10.1007/s12105-023-01550-0. PMID: 37027086Free PMC Article
Management of prolymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program 2015;2015:361-7. doi: 10.1182/asheducation-2015.1.361. PMID: 26637744
Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
Reindl L, Bacher U, Dicker F, Alpermann T, Kern W, Schnittger S, Haferlach T, Haferlach C
Br J Haematol 2010 Oct;151(1):25-36. Epub 2010 Jul 22 doi: 10.1111/j.1365-2141.2010.08299.x. PMID: 20649559
Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261
Cytogenetics in CLL and related disorders.
Juliusson G, Gahrton G
Baillieres Clin Haematol 1993 Dec;6(4):821-48. doi: 10.1016/s0950-3536(05)80178-7. PMID: 8038492

Clinical prediction guides

Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB, Chapiro E, Daudignon A, Nadal N, Penther D, Chauzeix J, Nguyen-Khac F, Veronese L, Lefebvre C
Curr Res Transl Med 2023 Oct-Dec;71(4):103428. Epub 2023 Oct 31 doi: 10.1016/j.retram.2023.103428. PMID: 38016421
Mycobacterial Spindle Cell Pseudotumor of the Nasal Cavity.
Argyris PP, Wakely PE Jr
Head Neck Pathol 2023 Sep;17(3):782-787. Epub 2023 Apr 7 doi: 10.1007/s12105-023-01550-0. PMID: 37027086Free PMC Article
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
Yee KW, Zeng Z, Konopleva M, Verstovsek S, Ravandi F, Ferrajoli A, Thomas D, Wierda W, Apostolidou E, Albitar M, O'Brien S, Andreeff M, Giles FJ
Clin Cancer Res 2006 Sep 1;12(17):5165-73. doi: 10.1158/1078-0432.CCR-06-0764. PMID: 16951235
Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261
Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD, Srivastava A, Srivastava BI
Leuk Lymphoma 1994 Jan;12(3-4):241-51. doi: 10.3109/10428199409059595. PMID: 7909467

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...